Research study Program year 2022 Source: CMS Open Payments

0000000000000000000000000000000000000000000000000000000000000000213312

Research payments

$3,181,412

46 payments

Through program year 2022, $3,181,412 in research payments was reported against 0000000000000000000000000000000000000000000000000000000000000000213312, across 46 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$590,297	9
2021	Research	$2,591,115	37

Breakdown

Who paid Research payments · program years 2021–2022

GlaxoSmithKline, LLC. $3,181,412 46 payments

Who received the money Research payments · program years 2021–2022

Multiple Myeloma Research Consortium Organisation paid for research $3,181,412 46 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.